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higher LDL cholesterol (13.7 vs. 12.8 mg/dL, p=0.07). By contrast, there were
no differences between the two groups as regards duration of HIV infection,
time of exposure to ARVs, (whether considered as a whole or by class), us-
CRP, or IL-6. Of the 45 patients with an abnormal CACS, 41 (91.1%) had
FRS <20% and would not have been eligible for cardiovascular prevention
treatment. These 41 patients represented 22.9% of all patients with FRS <20.
None of the 5 patients with CACS > 300 had been identified as high cardio-
vascular risk patients by FRS. 
Conclusion: In HIV-infected patients, CACS identified presence of coro-
nary atherosclerosis in 22.9% of patients who were deemed to be at low to
intermediate cardiovascular risk based on FRS. 
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Purpose: it has been postulated that outcome of poor metabolizers of clop-
idogrel may be worse in ACS patients. Data about the interest of assessing
platelet reactivity and genotyping in predicting outcome of patients with ACS
taking clopidogrel is still conflicting.
Methods: Prospectively, 120 successive patients (76,7% men, mean
age=60+/–12,2 years) with ACS 45% STEMI) were included. Patients were
excluded if not eligible to clopidogrel therapy or to the platelet activity test.
Patients were managed according to ESC guidelines. Platelet activity was assessed
by a VerifyNow P2Y12 test more than 24h after a 600mg clopidogrel loading
dose. DNA was extracted for genotyping of CYP1A1 and CYP2C19
(*1,*2,*3).MACE (death, infarction, stroke, coronary revascularization) was
assessed at 6 months.
Results: poor platelet inhibition (PRU>230) was noted 54 (46,6%) patients.
CYP1A1 and CYP2C19 low metabolizers (homo and heterozygosis) were respec-
tively 23.1% and 37,5%. MACE at 6 months was noted in 15 (12.5%) patients.
No significant correlation was found between MACE and platelet reactivity test
nor MACE and genotypes CYP1A1 and CYP2C19. combination of platelet
response and resistant genotypes didn’t help to predict MACE.
Conclusion: despite the high rates of poor responders to clopidogel in this
study, assessed by the verify now P2Y12 test and by genotyping (CYP1A1
and CYP2C19), no correlation has been found with MACE at 6 months.
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Introduction: In front of an important request for examination of myo-
cardal scintigraphy following a test of “litigious” effort, we are propose to
complete this work futurology with an aim of answering the question sug-
gested in title, in referent with the results of the myocardial tomoscintigraphy.
Materials and methods: Between January 2008 and May 2010, we investigate
186 consecutive patients presenting of the coronary risk factors addressed for
myocardal tomoscintigraphy in front of a test of litigious effort on the electric
level carried out within the framework of a search for quiet ischemia. Within
the service of nuclear medicine all the patients profited from a test of effort
according to the protocol of Bruce, followed by an examination tomoscintig-
raphy with the MIBI. In the event of a disorder perfusionnel with the myo-
cardic scintiscanning, the patient is taken again for an examination of rest. 
Results: There are 105 women and 81 men whose Middle Age is respec-
tively of 57,4 ± 9,3 years and 59,6 ± 8,2 years. The patients are diabetics in
66% of the cases, 78% are women, hypertensive in 53%. The other risk fac-
tors are also found with variable proportions. The tests of effort carried out
were all maximum. Four 92% of the tests of effort are negative clinically and
“wrongfully positive” electrically. The TSM of these patients is normal in
100% of the cases. In 8% of the cases, the test of effort is positive electrically,
the TSM is normal not detecting any disorder perfusionnel in 73% of the
cases, for the 4 other patients it objectifies disorders perfusionnels; the coron-
arography of these patients is pathological but without significant lesions
except for a patient. This last had in fact finished its test of effort by a non-
constant ventricular tachycardia suggesting a severe ischaemia confirmed with
the coronarography. 
Conclusion: A quite critical reading of under misalignment of the segment
ST during a test of effort diagnoses in particular at the time of the search for
a quiet ischemia, can avoid the recourse to other investigations
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Purpose: the aims of this study were to evaluate the novel biomarker
copeptin in combination with troponin I (cTnI), in patients with chest pain
presenting to the emergency department (ED), and to determine whether
copeptin may allow for a rapid rule out of acute myocardial infarction (AMI).
Previous data showed that combined measurement of copeptin and troponin
T(cTnT) improved diagnostic performance for rapid rule out of AMI.
Methods: in 97 patients presenting to the ED with suspicion of AMI, we
performed at admission, a conventional cTnI assay and a novel copeptin
assay.
Results: of 97 patients, 44 (45.4%) had the final diagnosis of AMI,
11(11.3%) of unstable angina and in 42 (43.3%) an acute coronary syndrome
(ACS) could be excluded. Patients with AMI, had copeptin levels higher than
patients with non ACS (20.12 vs 8.97pmol/l p<0.001). At admission, the aera
under curve (AUC) of the receiver-operating characteristic (ROC) curve for
the association cTnI / copeptin was not higher than AUC of cTnI (respectively
0.93 vs 0.89; p=0.177). In 60 patients with negative cTnI (< 0.044 μg/L),
copeptin (< 14 pmol/L) may allow to rule out AMI with sensitivity of 91.0%
and negative predictive value (NPV) of 97.4%.
Conclusions: conversely to what has been demonstrated for cTnT, no sig-
nificant difference in AUC was found when Copeptin/cTnI was compared to
cTnI alone. This can be explained by the limited set of patients and the rela-
tive good result of cTnI AUC. Only combined use of copeptin in negative
cTnI patients might help in ruling out AMI because of its good NPV and
hence improve triage of patients presenting with chest pain in ED.
080
The myocardial infarction of the young subject. Moroccan experience
Laila Bendriss [Orateur] (1), Sara Lamzarraf (2), Mustapha Ek Hattaoui
(3), Ali Khatouri (4)
(1) Hôpital Militaire Avicenne Marrakech Mar, Cardiologie, Marrakech,
Maroc – (2) Hôpital Ibn Tofail, Marrakech, Maroc – (3) Hôpital Ibn
Tofail, Cardiologie, Marrakech, Maroc – (4) Hôpital Militaire Avicenne
Marrakech Maroc, Cardiologie, Marrakech, Maroc
Purpose: The aim of this work is to study the specific epidemiological,
clinical, angiographic and evolving myocardial infarction (MI) of the young
subject.
Materials and methods: It is a descriptive retrospective study ruled in the
two services of cardiology of the UHC Mohammed VI de Marrakech from
January 2005 to October 2009. We included the patients admitted for MI and
paired them in two groups: group1 composed of young patients under 45 years
for men and 55 years for women, and group 2 of old patients beyond these age
limits. Patients in both groups were investigated focusing in epidemiological
analysis of cardiovascular risk factors, an ECG, a biological assessment and a
Doppler ultrasound cardiac examination (TTE). The coronarography wasn’t
realized in all cases. 
